Your browser doesn't support javascript.
loading
Dióxido de cloro y derivados del cloro para prevenir o tratar la COVID-19: revisión sistemática / Chlorine dioxide and chlorine derivatives for the prevention or treatment of COVID-19: a systematic review
Burela, Alejandra; Hernández-Vásquez, Akram; Comandé, Daniel; Peralta, Verónica; Fiestas, Fabian.
Affiliation
  • Burela, Alejandra; EsSalud. Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI. Lima. PE
  • Hernández-Vásquez, Akram; EsSalud. Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI. Lima. PE
  • Comandé, Daniel; Instituto de Efectividad Clínica y Sanitaria (IECS). Buenos Aires. AR
  • Peralta, Verónica; EsSalud. Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI. Lima. PE
  • Fiestas, Fabian; EsSalud. Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI. Lima. PE
Rev. peru. med. exp. salud publica ; 37(4): 605-610, oct.-dic. 2020. graf
Article in Spanish | LILACS | ID: biblio-1156819
Responsible library: PE14.1
RESUMEN
RESUMEN

Objetivos:

Realizar una revisión sistemática acerca de la efectividad y seguridad del uso de dióxido de cloro y derivados del cloro, en la prevención o el tratamiento de la COVID-19. Materiales y

métodos:

Se siguieron las pautas internacionales de elaboración de revisiones sistemáticas de PRISMA y el Manual Cochrane para revisiones sistemáticas de intervenciones. La estrategia de búsqueda la desarrolló un bibliotecario y la revisaron dos de los autores. Se complementó la búsqueda electrónica con una búsqueda manual. Se incluyeron ensayos clínicos aleatorizados, estudios cuasiexperimentales, estudios de cohorte, estudios de casos y controles, estudios de corte transversal y reportes de casos; y se excluyeron estudios in vitro o realizados en animales. Dos revisores, de forma independiente, seleccionaron los estudios según los criterios de elegibilidad definidos, usando el aplicativo web Rayyan, en caso de discordancia se hizo partícipe a un tercer revisor. El protocolo de la revisión sistemática se registró en PROSPERO (CRD42020200641).

Resultados:

No se identificó ningún estudio publicado ni en proceso de publicación que haya evaluado el uso del dióxido de cloro o derivados del cloro, administrado por vía inhalatoria, oral o parenteral en humanos, como agente preventivo o terapéutico de la COVID-19 o en infecciones por otros coronavirus. Solo se identificó el registro de un único estudio catalogado como observacional que hasta ahora no tiene resultados.

Conclusiones:

A la fecha, no existe evidencia científica que apoye el uso del dióxido de cloro o derivados del cloro para prevenir o tratar la COVID-19.
ABSTRACT
ABSTRACT

Objectives:

To systematically review the effectiveness and safety of chlorine dioxide solution and chlorine derivatives used in the prevention or treatment of COVID-19.

Methods:

This review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) and follows the guidelines provided in the Cochrane Handbook for Systematic Reviews of Interventions. A librarian developed and executed the search strategy; it was further reviewed by two of the authors and complemented by manual search. Randomized clinical trials, quasi-experimental studies, cohort studies, case-control studies, cross-sectional studies, and case reports were included; in vitro or animal studies were excluded. Abstract and full-text screening according to pre-defined eligibility criteria were performed by two reviewers independently using web application Rayyan QCRI. Disagreements on study selection were resolved by a third reviewer. The systematic review protocol was registered in PROSPERO (CRD42020200641).

Results:

Neither published nor pre-print studies evaluating the use of chlorine dioxide or derivatives on SARS-CoV-2 infection were identified. The only finding was an unpublished observational study registry which has no results released yet.

Conclusions:

To date, there are no scientific evidence to uphold the use of chlorine dioxide or derivatives as preventive or therapeutic agents against COVID-19.
Subject(s)


Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Pneumonia Database: LILACS Main subject: Chlorine Dioxide / Systematic Review / COVID-19 Type of study: Controlled clinical trial / Practice guideline / Observational study / Prevalence study / Prognostic study / Systematic review Language: Spanish Journal: Rev. peru. med. exp. salud publica Journal subject: Public Health Year: 2020 Document type: Article Affiliation country: Argentina / Peru Institution/Affiliation country: EsSalud/PE / Instituto de Efectividad Clínica y Sanitaria (IECS)/AR

Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Pneumonia Database: LILACS Main subject: Chlorine Dioxide / Systematic Review / COVID-19 Type of study: Controlled clinical trial / Practice guideline / Observational study / Prevalence study / Prognostic study / Systematic review Language: Spanish Journal: Rev. peru. med. exp. salud publica Journal subject: Public Health Year: 2020 Document type: Article Affiliation country: Argentina / Peru Institution/Affiliation country: EsSalud/PE / Instituto de Efectividad Clínica y Sanitaria (IECS)/AR
...